ACS-IRG Grant Awarded

The Sheynkman lab is proud to announce that we have been awarded an American Cancer Society Institutional Research Grant (ACS-IRG) for “Targeted proteogenomics technology to characterize isoforms associated with silent driver mutations in melanoma”. This grant will allow us to continue developing proteomics technologies for identifying and characterizing isoforms that are drivers in melanoma and other cancers and human diseases.